This international, peer-reviewed Open Access journal by Dove Medical Press focuses on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.
Neuropsychiatric Disease and Treatment is an international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders. The intended audience is researchers, academics, key opinion leaders and regulatory authorities.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Follow this link for information on the Editors and the Editorial Board Members.
Open Access Publication: All manuscripts submitted to Dove Medical Press are assumed to be submitted under the Open Access publishing model.
In this publishing model, papers are peer-reviewed in the normal way under editorial control. When a paper is accepted for publication the author is issued with an invoice for payment of a publication processing fee. Publication processing fees invoiced to EU countries are subject to 20% VAT. There is no submission charge as such, only the publication processing fee after the paper is accepted for publication. Payment of this charge allows Dove Medical Press to recover its editorial and production costs and create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries.
For more information on the publishing process and publishing fees follow this link.
|ScienceOpen disciplines:||Neurology, Internal medicine, Neurosciences, Human biology, Clinical Psychology & Psychiatry|
|Keywords:||clinical therapeutics, pharmacology, clinical studies, pre-clinical studies, neuropsychiatry, neurology, neurological disorders, neuropsychiatric disorders|